Octagon Capital Advisors »

Terns Pharmaceuticals shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.3M 1.4M 6.81
2024-03-31 $4.1M 625k 6.56

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals Call Option (APLS)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Structure Therapeutics Sponsored Ads (GPCR)
Dyne Therapeutics (DYN)
Arrivent Biopharma (AVBP)
Verona Pharma Sponsored Ads (VRNA)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)
Ocular Therapeutix (OCUL)
Perspective Therapeutics Com New (CATX)
Mind Medicine Mindmed Com New (MNMD)
Praxis Precision Medicines I Com New (PRAX)
Taysha Gene Therapies Com Shs (TSHA)

View all positions for Octagon Capital Advisors

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Deep Track Capital
Soleus Capital Management
BlackRock
VR Adviser
Point72 Asset Management
Vanguard Group
Schonfeld Strategic Advisors
Citadel Advisors
Octagon Capital Advisors
Millennium Management
State Street Corporation
Dr. Jeffrey R. Jay, M.D.
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals